Hope in a pill: can a japanese flu drug beat ebola?
NCT ID NCT02329054
First seen Nov 18, 2025 · Last updated May 12, 2026 · Updated 21 times
Summary
This study tested a drug called favipiravir, originally developed for flu, to see if it could lower the death rate in people with Ebola. 126 patients in Guinea took high doses of the oral drug. The goal was to find a safe, easy-to-use treatment that could be given in outbreak zones.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EBOLA VIRUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ALIMA Ebola care center
Nzérékoré, Guinea
-
French Red Cross Ebola care center
Macenta, Guinea
-
MSF Ebola treatment centre
Gueckedou, Guinea
-
The caregivers treatment center
Conakry, Guinea
Conditions
Explore the condition pages connected to this study.